These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3111689)

  • 1. Antianginal efficacy and tolerability of 50 mg sustained-release isosorbide 5-mononitrate in an open twelve-month observation study.
    Heepe W; Gathmann-Lewik U
    Cardiology; 1987; 74 Suppl 1():34-9. PubMed ID: 3111689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slow-release isosorbide-5-mononitrate--a new once daily therapeutic modality for angina pectoris.
    Ahmadinejad M; Eghbal B; Sorgenicht W; Schneeweiss A; Weiss M
    Eur Heart J; 1988 Jan; 9 Suppl A():135-9. PubMed ID: 3137063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized crossover trial of isosorbide mononitrate (Elantan 20) and slow-release glyceryl trinitrate in the treatment of angina pectoris.
    Brodie NH; O'Hara H; O'Hara J; Valle-Jones JC
    Pharmatherapeutica; 1985; 4(6):367-75. PubMed ID: 3936056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained-release IS-5-MN in the treatment of coronary heart disease.
    Keck M
    Cardiology; 1991; 79 Suppl 2():51-7. PubMed ID: 1760831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intraindividual dose-response relationship of sustained-release Elantan].
    Kenedi P
    Z Kardiol; 1986; 75 Suppl 3():77-9. PubMed ID: 3541420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of coronary heart disease with isosorbide mononitrate ('Elantan' 20): a multi-centre study in hospital and general practice.
    Marten W; Weiss M; Haase W
    Curr Med Res Opin; 1984; 9(2):96-106. PubMed ID: 6443349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the antianginal and anti-ischemic efficacy of slow-release isosorbide-5-mononitrate capsules, bupranolol and their combination, in patients with chronic stable angina pectoris.
    Krepp HP
    Cardiology; 1991; 79 Suppl 2():14-8. PubMed ID: 1760823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment].
    Mertens HM; Ohlmeier H; Mannebach H; Kabelitz K; Gleichmann U
    Herz; 1985 Jun; 10(3):172-81. PubMed ID: 3926614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrupt withdrawal of isosorbide-5-mononitrate in Durules (Imdur) after long term treatment in patients with stable angina pectoris.
    Rehnqvist N; Olsson G; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G; Uusitalo A; Keyriläinen O; Reinikainen P
    Eur Heart J; 1988 Dec; 9(12):1339-47. PubMed ID: 3147892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term efficacy of a controlled-release formulation of isosorbide 5-mononitrate (Imdur) in angina patients receiving beta-blockers.
    Uusitalo A
    Drugs; 1987; 33 Suppl 4():111-7. PubMed ID: 2887418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
    Neuhaus R; Johnen R; Vydra L; Solbach C
    Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of effectiveness and tolerability of isosorbide mononitrate during a three-year period in patients with angina pectoris.
    May K; Eghbal B; Ahmadinejad M; Ensslin HD; Weiss M
    Cardiology; 1991; 79 Suppl 2():46-50. PubMed ID: 1760829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal nitrate therapy with a once-daily sustained-release formulation of isosorbide mononitrate.
    Waller DG
    J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 2():S21-7; discussion S29-31. PubMed ID: 10499557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open, long-term, multi-centre study of the anti-anginal efficacy and safety of isosorbide 5-mononitrate at low doses in patients with coronary heart disease.
    Uberbacher HJ; Steinorth G; Glocke M; Abshagen U
    Pharmatherapeutica; 1983; 3(5):331-41. PubMed ID: 6342004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abrupt withdrawal of isosorbide 5-mononitrate (Imdur) after long term treatment in stable angina pectoris. A preliminary report.
    Rehnqvist N; Olsson G; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G; Uusitalo A; Keyriläinen O; Härkönen R
    Drugs; 1987; 33 Suppl 4():118-21. PubMed ID: 2887419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selection of therapy with nitrates in patients with stable effort angina: results of comparative study of common isosorbide dinitrate and long acting preparation of isosorbide-5-mononitrate].
    Martsevich SIu; Semenova IuE; Alimova EV; Dmitrieva nA; Kozyreva MP; Koniakhina IP; Lukina IuV; Egorov VA
    Kardiologiia; 2005; 45(11):42-5. PubMed ID: 16353064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of diltiazem and isosorbide-5-mononitrate, alone and in combination, on patients with stable angina pectoris.
    Emanuelsson H; Ake H; Kristi M; Arina R
    Eur J Clin Pharmacol; 1989; 36(6):561-6. PubMed ID: 2506059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-angina action and tolerance of isosorbide-5-mononitrate or nifedipine in retard form].
    Erlemeier HH; Kupper W; Lange S; Bleifeld W
    Z Kardiol; 1986; 75 Suppl 3():112-4. PubMed ID: 3541415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
    Thadani U
    Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and duration of action of isosorbide-5-mononitrate in the treatment of stable angina of effort. Comparison with sustained-release isosorbide dinitrate].
    Lagioia R; Scrutinio D; Mangini SG; De Toma L; Accettura D; De Nicolò M; Saliani P; Preziusi N; Antuofermo F; Rizzon P
    G Ital Cardiol; 1985 Mar; 15(3):299-306. PubMed ID: 4018470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.